Health. Quality. Life.
hu en
Search
Skip to main content
 
 
About Us

In 2013 we celebrate the 100th anniversary of the foundation of our legal predecessor. Our main market is Hungary, we export to 62 countries...

 		  Innovation

The ratio of our R&D investments and turnover is the highest in Hungary and the third highest in Central Eastern Europe...

 		  Products

In our Hungarian plants we produce 4.1 billion tablets, 140 million boxes of medicines and 566 tons of active ingredients yearly...

 		  For Investors

Publicly traded company whose shares are listed on the Budapest Stock Exchange since 1994. Our financial reports are published quarterly...

 

In the frame of a new strategy we renew the product portfolio and our operations opening towards new markets... »

  

 

We have won six Innovation Prizes with our generic developments. .. »

  

 

Every tenth medicine sold in Hungary is produced by EGIS. We sell the biggest number of cardiovascular products... »

  

 

51% of our shares are owned by the French Servier through its subsidiary, ATP... »
Site Map Privacy policy Print
About Us The CEO’s welcome Our activities EGIS in the world Our history Our results Awards and Prizes Innovation Generic development Original research Patents Innovation Prizes Products Finished products Active ingredients For Investors Corporate News Company Information Equities Information Reports, presentations AGM, Dividend Payment Corporate Calendar Social Responsibility Health care Environment protection Quality assurance Pharmacovigilance CSR reports Disclaimer Contact